After two decades in the making, scientists have cracked the code on a drug that can repair DNA, setting the scene for a new ...

Baylor College of Medicine will be a site for a new multi-institution project aimed at investigating preclinical drug safety ...

A heart attack does more than block blood flow. Inside your body, it unleashes chaos. Heart cells flood with harmful oxygen ...

Experts released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM). The guideline reiterates the importance of collaborative ...

Björn Pasternak, M.D., Ph.D. A new class of type 2 diabetes drug appears to reduce the risk of heart failure, death and major cardiovascular events, Scandinavian researchers have found. The results ...

TY1 enhances the action of TREX1, a gene that helps immune cells clear damaged DNA, helping to minimize scar tissue post heart attacks.

African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...

Updates to national guidelines for the management of hypertrophic cardiomyopathy (HCM) endorse cardiac myosin inhibitor use in certain cases, greenlight more intensive physical activity, and expand ...

Aficamten shows cardiac benefits over blood pressure drug metoprolol Analysts see potential for aficamten to replace beta-blocker drugs for treating HCM Cytokinetics plans to submit data to regulators ...

ORLANDO, Fla./NEW YORK, Nov 5 (Reuters) - Researchers have been unable to nail down the cause of increased deaths that led Pfizer Inc to drop its once-promising cholesterol drug torcetrapib, leaving a ...